Hematopoietic Stem Cell TransplantationTransplantation, HomologousStem Cell TransplantationGraft vs Host DiseaseTransplantation ConditioningTransplantation, AutologousPeripheral Blood Stem Cell TransplantationHematologic NeoplasmsTransplantation ChimeraTreatment OutcomeStem CellsBone Marrow TransplantationAntineoplastic Combined Chemotherapy ProtocolsGraft vs Leukemia EffectMyeloablative AgonistsBusulfanTissue DonorsRemission InductionRecurrenceVidarabineGraft vs Tumor EffectCombined Modality TherapyGraft SurvivalHistocompatibility TestingDisease-Free SurvivalMultiple MyelomaLymphocyte TransfusionLeukemia, Myeloid, AcuteImmunosuppressive AgentsSurvival AnalysisSalvage TherapyLeukemiaRetrospective StudiesSurvival RateCyclophosphamideHematopoietic Stem CellsSiblingsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveWhole-Body IrradiationCord Blood Stem Cell TransplantationCytomegalovirus InfectionsMinor Histocompatibility AntigensMelphalanMyelodysplastic SyndromesNeoplasm, ResidualLymphocyte DepletionPrecursor Cell Lymphoblastic Leukemia-LymphomaLiver TransplantationAntilymphocyte SerumVirus ActivationHistocompatibilityTime FactorsAntineoplastic AgentsHematopoietic Stem Cell MobilizationChimerismHepatic Veno-Occlusive DiseasePrognosisFollow-Up StudiesT-LymphocytesMesenchymal Stem Cell TransplantationCytomegalovirusAcute DiseaseCytarabineCell TransplantationHematologic DiseasesAnemia, AplasticPrimary MyelofibrosisHLA AntigensAntigens, CD34Hodgkin DiseaseKidney TransplantationLymphoma, Non-HodgkinEmbryonic Stem CellsEtoposideLeukemia, Myeloid, Accelerated PhaseAntibodies, NeoplasmLeukemia, MyeloidImmunosuppressionTransplantation ImmunologyGranulocyte Colony-Stimulating FactorBenzamidesImmunocompromised HostRoseolovirus InfectionsAdult Stem CellsLymphoproliferative DisordersChemotherapy, AdjuvantFusion Proteins, bcr-ablPyrimidinesReceptors, Purinergic P2X5Prospective StudiesImmunotherapy, AdoptiveFatal OutcomeInfectionGraft RejectionAntibodies, MonoclonalNuclear FamilyStomatitisPiperazinesCyclosporineGanciclovir